You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博瑞醫藥(688166.SH):董事長收到江蘇證監局警示函
格隆匯 10-17 18:54

格隆匯10月17日丨博瑞醫藥(688166.SH)公佈,董事長袁建棟於近日收到中國證券監督管理委員會江蘇監管局下達的《江蘇證監局關於對袁建棟採取出具警示函措施的決定》,經查,作為博瑞醫藥董事長、總經理,在2023年10月12日下午召開的“大咖解讀GLP-1全產業鏈系列交流會”電話會議上發佈了個人試用公司在研產品BGM0504注射液相關情況。目前BGM0504注射液用於減重尚處於臨牀試驗階段,有效性尚不明確,關於藥效的相關言論具有誤導性,違反了《上市公司信息披露管理辦法》第四十九條第二款的規定。

根據《信披辦法》第五十二條的規定,我局決定對其採取出具警示函的行政監管措施,並記入證券期貨市場誠信檔案。你應認真汲取教訓,加強對證券法律法規的學習,保證披露信息的真實、準確、完整,杜絕此類違規行為再次發生,並在收到本決定書之日起十個工作日內向我局提交書面報吿。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account